ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.2335
-0.0246 (-9.53%)
At close: Nov 19, 2025, 4:00 PM EST
0.2370
+0.0035 (1.50%)
After-hours: Nov 19, 2025, 7:24 PM EST
ProPhase Labs Employees
ProPhase Labs had 96 employees as of December 31, 2024. The number of employees decreased by 17 or -15.04% compared to the previous year.
Employees
96
Change (1Y)
-17
Growth (1Y)
-15.04%
Revenue / Employee
$64,969
Profits / Employee
-$558,500
Market Cap
9.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 96 | -17 | -15.04% |
| Dec 31, 2023 | 113 | -16 | -12.40% |
| Dec 31, 2022 | 129 | 0 | - |
| Dec 31, 2021 | 129 | 34 | 35.79% |
| Dec 31, 2020 | 95 | 45 | 90.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRPH News
- 3 hours ago - ProPhase Labs, Inc. (PRPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 hours ago - ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - GlobeNewsWire
- 1 day ago - ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 - GlobeNewsWire
- 2 days ago - ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals - GlobeNewsWire
- 21 days ago - ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology - GlobeNewsWire
- 22 days ago - ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts - GlobeNewsWire
- 26 days ago - ProPhase Labs to Present at the 2025 ThinkEquity Conference - GlobeNewsWire
- 4 weeks ago - ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology - GlobeNewsWire